Format

Send to

Choose Destination
Eur J Med Chem. 2009 Oct;44(10):3874-9. doi: 10.1016/j.ejmech.2009.04.008. Epub 2009 Apr 14.

Didanosine ester prodrugs: synthesis, albumin binding properties and pharmacokinetic studies in rats.

Author information

1
Department of Pharmaceutical Chemistry, School of Pharmacy, University of Oslo, Blindern N-0315 Oslo, Norway.

Erratum in

  • Eur J Med Chem. 2009 Nov;44(11):4786. Standal, Marius [removed].

Abstract

Three half-ester derivatives 10-12 of 5'-O-2',3'-dideoxydidanosine (DDI, 1) have been synthesized. The compounds exhibited excellent correlation between partition coefficients LogP and relative in vitro bovine serum albumin binding. Using high-performance liquid chromatography-mass spectrometry (LC-MS), DDI (1) was quantitatively determined in rat plasma after intravenous injection of the azelaic acid monoester derivative (11) of DDI. The pharmacokinetic data obtained for DDI were consistent with literature. The pharmacokinetic profile of 11 showed no significant difference in AUC(0-360) or curve shape compared to the parent drug DDI (1). The data indicate that the prodrug was converted to DDI within minutes after administration. High relative protein binding in vitro holds a promise for validity of the concept using more stable linker bonds.

PMID:
19433342
DOI:
10.1016/j.ejmech.2009.04.008
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science Icon for University of Oslo Library
Loading ...
Support Center